NCT05559424

Brief Summary

Single-stent strategy with provisional approach represents the gold standard for percutaneous coronary intervention of bifurcation lesions, and, according to European Bifurcation Club, performing provisional approach presents two steps considered as mandatory: "crossover stenting" in main vessel (MV) and subsequent post-dilation or "POT" (proximal optimization technique). While consensus exists regarding these first two steps, the exact optimal following sequence in case of side branch (SB) jeopardize after main vessel stenting is still a matter of debate. Actually, the two most used techniques in this setting are represented by the simultaneous inflation of two balloons located respectively in the MV and SB followed by a second POT (POT/kissing balloon/POT technique) and the isolated inflation of a balloon placed in the SB followed by a second POT (POT/SIDE/POT technique). The objective of this study is to compare the configuration achieved with POT/KISS/POT (PKP) and POT/SIDE/POT (PSP), using the "cutting edge" high-resolution intracoronary imaging modality (Optical Coherence Tomography, OCT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

October 18, 2022

Status Verified

October 1, 2022

Enrollment Period

9 months

First QC Date

September 26, 2022

Last Update Submit

October 16, 2022

Conditions

Keywords

ProvisionalOCTkissing balloonbifurcations

Outcome Measures

Primary Outcomes (1)

  • Stent expansion

    Minimum stent expansion

    Intra-procedural

Secondary Outcomes (10)

  • Side branch ostial scaffolding length

    Intra-procedural

  • Stent eccentricity index

    Intra-procedural

  • Stent complications

    Intra-procedural

  • Additional treatment after OCT

    Intra-procedural

  • Stent malapposition

    Intra-procedural

  • +5 more secondary outcomes

Study Arms (2)

POT/KISSING/POT (PKP)

ACTIVE COMPARATOR

* SB rewiring is performed with the objective to cross "distal" stent struts (distal rewiring) through pullback technique. * KBI is performed using short non-compliant balloons (balloon of MV sized in a 1:1 ratio with distal MV reference diameter and SB balloon sized in a 1:1 ratio with SB reference diameter), with sequential followed by simultaneous inflation. * Final POT is performed at the same way as initial POT

Diagnostic Test: OCT

POT/SIDE/POT (PSP)

ACTIVE COMPARATOR

* SB rewiring is performed with the objective to cross "distal" stent struts (distal rewiring) through pullback technique. * SB dilatation is performed with a balloon sized 1:1 according to SB reference diameter. * Final POT is performed at the same way as initial POT.

Diagnostic Test: OCT

Interventions

OCTDIAGNOSTIC_TEST

OCT will be used to assess results after intervention

POT/KISSING/POT (PKP)POT/SIDE/POT (PSP)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has coronary artery disease involving a bifurcation with evidence of myocardial ischemia, including patient with chronic coronary syndromes, unstable angina, or non-ST elevation-acute coronary syndromes (NSTE-ACS) hemodynamically stable.
  • Subject is suitable to be treated by PCI according to operator's judgement or heart team decision.
  • PCI planning includes provisional stenting and image guidance by OCT use.
  • Patient is aged ≥ 18 years.
  • Patient can provide written informed consent
  • \- De novo coronary lesion involving the left main bifurcation, or a bifurcation lesion not located in the left main with large branches (distal MV reference diameter ≥ 3.5 mm and SB reference diameter ≥ 2.75 mm on visual estimation)

You may not qualify if:

  • Acute coronary syndromes with ST-elevation (STE-ACS)
  • Cardiogenic shock
  • LVEF ≤ 30%
  • Pregnancy
  • Known severe thrombocytopaenia (platelet count \< 50,000/mm3)
  • eGFR ≤ 30 mL/min/m2 (Cockcroft-Gault)
  • Contraindications to antiplatelet drugs/anticoagulant drugs
  • Significant allergic reactions for contrast agent
  • Women with pregnancy potential.
  • Target chronic total occlusion
  • Planned 2 stent-strategy
  • Target bifurcation lesion has a previously implanted stent
  • Target graft lesions
  • Medina 0.0.1 target lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico A. Gemelli. Università Cattolica del Sacro Cuore

Rome, 00168, Italy

Location

MeSH Terms

Conditions

Myocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Francesco Burzotta, MD, PhD

    Catholic University of the Sacred Heart

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francesco Burzotta, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Before enrollment start, the plausibility of the study hypothesis will be verified in an experimental pilot randomized investigation conducted n an ex-vivo beating heart animal model
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 29, 2022

Study Start

October 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

October 18, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations